| Kristin Tompkins Mizerik, MD | |
|
300 North Avenue, Outpatient Center, Battle Creek, MI 49017-4901 | |
| (855) 618-2676 | |
| Not Available |
| Full Name | Kristin Tompkins Mizerik |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 12 Years |
| Location | 300 North Avenue, Outpatient Center, Battle Creek, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194088567 | NPI | - | NPPES |
| 300049470 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 01085567A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Methodist Hospital | 0244148633 | 598 |
| Bronson Battle Creek Hospital | 0547173478 | 157 |
News Archive
The polysaccharide (sugar substance) chitosan has a documented antibacterial effect. Hilde Mellegård's doctoral research shows that this antibacterial activity varies according to the chemical composition of the chitosan.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Joint injury can lead to post-traumatic osteoarthritis (PTOA). In fact, about half of all people who rupture the anterior cruciate ligament (ACL) in their knee will develop PTOA within 10-20 years of the injury.
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
› Verified 6 days ago
| Entity Name | Bronson Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
The polysaccharide (sugar substance) chitosan has a documented antibacterial effect. Hilde Mellegård's doctoral research shows that this antibacterial activity varies according to the chemical composition of the chitosan.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Joint injury can lead to post-traumatic osteoarthritis (PTOA). In fact, about half of all people who rupture the anterior cruciate ligament (ACL) in their knee will develop PTOA within 10-20 years of the injury.
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
› Verified 6 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
The polysaccharide (sugar substance) chitosan has a documented antibacterial effect. Hilde Mellegård's doctoral research shows that this antibacterial activity varies according to the chemical composition of the chitosan.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Joint injury can lead to post-traumatic osteoarthritis (PTOA). In fact, about half of all people who rupture the anterior cruciate ligament (ACL) in their knee will develop PTOA within 10-20 years of the injury.
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Tompkins Mizerik, MD Po Box 2526, Fort Wayne, IN 46801-2526 Ph: (260) 436-8686 | Kristin Tompkins Mizerik, MD 300 North Avenue, Outpatient Center, Battle Creek, MI 49017-4901 Ph: (855) 618-2676 |
News Archive
The polysaccharide (sugar substance) chitosan has a documented antibacterial effect. Hilde Mellegård's doctoral research shows that this antibacterial activity varies according to the chemical composition of the chitosan.
InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.
Joint injury can lead to post-traumatic osteoarthritis (PTOA). In fact, about half of all people who rupture the anterior cruciate ligament (ACL) in their knee will develop PTOA within 10-20 years of the injury.
CollegeAIM, a new resource to help college officials address harmful and underage student drinking, is now available. The CollegeAIM (Alcohol Intervention Matrix) guide and website was developed by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.
› Verified 6 days ago
Theodore C Yee, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 269-969-6251 Fax: 269-969-6283 | |
John C Morgan, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 269-969-6251 Fax: 269-969-6283 | |
Dr. Daniel X Garcia, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2 Heritage Oak Ln, Battle Creek, MI 49015 Phone: 269-979-6360 Fax: 269-979-6380 | |
Dr. Phillip John Dabrowski, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 877-704-3133 | |
Mark Dean Russell, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2 Heritage Oak Ln, Battle Creek, MI 49015 Phone: 269-979-6360 Fax: 269-979-6380 | |
Dr. William J Comai, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 North Ave, Battle Creek, MI 49017 Phone: 269-969-6251 Fax: 269-969-6283 |